Salt Lake City, UT, United States of America

Christian Con Yost

This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: University of Utah Research Foundation, Ballard Spahr LLP. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Con Yost. Retrieved from https://idiyas.com/inventor/christian-con-yost

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.3

ph-index = 1

Location History:

Salt Lake City, UT (US) (2020 - 2022)
North Salt Lake, UT (US) (2019 - 2023)

Company Filing History:

4 out of 1,685

University of Utah Research Foundation

Years Active: 2019-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11752203 - Methods for treatment of and prophylaxis against inflammatory disorders (2023-09-12),

2. 11324801 - NNIF and nNIF-related peptides and related methods (2022-05-10),

3. 10857201 - NNIF and nNIF-related peptides and related methods (2020-12-08),

4. 10646556 - Methods for treatment of and prophylaxis against inflammatory disorders (2020-05-12),

5. 10232023 - Methods for treatment of and prophylaxis against inflammatory disorders (2019-03-19),

Title: Christian Con Yost: Innovator in Inflammatory Disorder Treatments

Introduction

Christian Con Yost is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medical treatments, particularly focusing on inflammatory disorders and cancer. With a total of 5 patents to his name, Yost's work has the potential to impact many lives.

Latest Patents

Yost's latest patents include innovative methods for the treatment and prophylaxis against inflammatory disorders. One of his key inventions is an isolated and purified peptide known as the neonatal NET-inhibitory Factor (nNIF). This invention outlines methods that involve administering NET-inhibitory peptides (NIPs), which may include nNIF and its analogs, to individuals suffering from inflammatory disorders. Additionally, he has developed methods for the treatment of cancer, including strategies for inhibiting metastasis in patients at risk of developing inflammatory disorders or cancer.

Career Highlights

Throughout his career, Yost has worked with esteemed organizations such as the University of Utah Research Foundation and Ballard Spahr LLP. His work in these institutions has allowed him to further his research and develop groundbreaking treatments.

Collaborations

Yost has collaborated with notable individuals in his field, including Guy A. Zimmerman and Andrew S. Weyrich. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Christian Con Yost is a pioneering inventor whose work in the treatment of inflammatory disorders and cancer showcases his dedication to medical innovation. His contributions are poised to make a significant difference in the healthcare landscape.

Profile summary based on public USPTO records.